InvestorNewsBreaks

Thursday Sep 10, 2026 - 10:39 am

InvestorNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Named to 2026 TSX30 Following 570% Share Price Increase

This article has been disseminated on behalf of Trilogy Metals Inc. and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) announced it has been named to the 2026 TSX30, an annual ranking of the top-performing companies on the Toronto Stock Exchange over a three-year period based on dividend-adjusted share price appreciation. Trilogy share price increased 570% during the three years ended June 30, 2026. President and CEO Tony Giardini said the recognition…

Thursday Sep 10, 2026 - 10:20 am

InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 2 Psilocybin Trial for Major Depressive Disorder

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for major depressive disorder (“MDD”) in the first half of 2027, with dosing expected to be completed by year-end. The Health Canada-authorized trial will enroll up to 200 participants…

Thursday Sep 10, 2026 - 10:10 am

InvestorNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Launches Overwatch Patrol for GPS-Denied Dismounted Operations

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) launched Overwatch Patrol, a dismounted positioning application designed to provide continuous location information to soldiers and security personnel when GPS is jammed, spoofed, degraded or unavailable. Unveiled at the International Defense Industry Exhibition (“MSPO”) in Kielce, Poland, Overwatch Patrol operates through…

Thursday Sep 10, 2026 - 10:00 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) is advancing Lucid-MS toward a randomized, double-blind, placebo-controlled phase 2 trial in multiple sclerosis (“MS”) following U.S. Food and Drug Administration (“FDA”) clearance of its Investigational New Drug (“IND”) application. Lucid-MS is a patented, first-in-class, non-covalent inhibitor of peptidyl arginine deiminase 2 (“PAD2”) designed to target…

Thursday Sep 10, 2026 - 9:50 am

InvestorNewsBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Reports 79% Growth in SSi Mantra Procedures, Expands Global Reach

SS Innovations International (NASDAQ: SSII) provided an update on the continued expansion and utilization of its SSi Mantra surgical robotic system, reporting 14,103 cumulative procedures as of Sept. 8, 2026, up 79% from 7,885 at year-end 2025, while its installed base increased 42% to 238 systems from 168. The SSi Mantra is now installed across 12 countries, approximately 1,500 physicians have been trained on the…

Thursday Sep 10, 2026 - 9:45 am

InvestorNewsBreaks – American Fusion Inc. (OTC: AMFN) Highlights Texatron(TM) Fusion Engine(TM) Development, AI Power Strategy in New Interview

American Fusion (OTC: AMFN) announced the release of a new AGORACOM interview featuring Executive Chairman Brent Nelson discussing development of the company proprietary Texatron(TM) Fusion Engine(TM) and its strategy for addressing growing electricity demand from artificial intelligence, data centers and other power-intensive applications. Nelson discusses the company 5 MW preproduction Texatron(TM), plans for 10 MW and 20 MW systems and Texas authorization to test 12 planned system sizes ranging from approximately 500 kW…

Thursday Sep 10, 2026 - 9:40 am

InvestorNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Advances Montauban Commissioning as Key Processing Equipment Arrives

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising. ESGold (CSE: ESAU) (OTCQB: ESAUF) announced the arrival of additional processing equipment at its fully permitted Montauban Gold-Silver Project in Québec as installation, integration and commissioning continue across its 1,000-tonne-per-day processing facility. The equipment includes a Sepro Mineral Systems Falcon Gravity Concentrator designed to support precious-metal recovery and industrial thickeners…

Thursday Sep 10, 2026 - 9:30 am

InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in Morgan Stanley Global Healthcare Conference

This article has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) announced that CEO Michael Halstead will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City. The fireside chat will be webcast live Sept. 16 at 8:30 a.m. EDT, with a replay available on the…

Thursday Sep 10, 2026 - 9:20 am

InvestorNewsBreaks – Rezolve Ai (NASDAQ: RZLV) CEO to Participate at H.C. Wainwright Global Investment Conference, Company Sets Oct. 6 Investor Day

Rezolve Ai (NASDAQ: RZLV) announced that Founder and CEO Daniel M. Wagner will participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York City, scheduled for Sept. 14-16, 2026. The company will also host an Investor Day on Oct. 6 at Nasdaq MarketSite in New York City, where it will present its agentic commerce business and expanding AI infrastructure capabilities to investors…

Thursday Sep 10, 2026 - 9:10 am

InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) CMO Discusses ONC010, Novel PNKP Target in BioMedWire Podcast

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) Chief Medical Officer Dr. Islam Mohamed joined IBN BioMedWire Podcast to discuss lead drug candidate ONC010, the company novel approach to targeting the DNA repair enzyme polynucleotide kinase phosphatase (“PNKP”) and its planned first-in-human clinical program. Mohamed highlighted ONC010 two…

Thursday Sep 10, 2026 - 9:05 am

InvestorNewsBreaks – SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Advances Super Nova(TM) Modular Hybrid Quantum Computer

This article has been disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertising. SuperQ Quantum (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) is actively developing its flagship Super Nova(TM) modular hybrid quantum computer, with the quantum hardware layer being developed at the University of Waterloo Digital Quantum Matter Lab under the supervision of superconducting quantum physics expert Professor Matteo Mariantoni. Designed to integrate with enterprise IT and high-performance computing infrastructure,…

Thursday Sep 10, 2026 - 9:00 am

InvestorNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Appoints Billy Choi as Chief Financial Officer

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced it has hired Billy Choi as its new chief financial officer, with Choi expected to assume full CFO responsibilities in October 2026 following a transition period. Choi most recently served as vice president of finance at Lithium Royalty Corp., where he was…

Wednesday Sep 09, 2026 - 2:05 pm

InvestorNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Urges SkyAI Shareholders to Oppose Equity Plan, Withhold Votes on Director Nominees

Forward Industries (NASDAQ: FWDI) issued an open letter to SkyAI shareholders outlining concerns about the company and urging shareholders to vote against SkyAI’s 2026 Equity Incentive Plan and withhold votes on each of its five director nominees at the Sept. 18, 2026, annual meeting. Forward cited SkyAI’s rejection of its June 15 all-stock acquisition proposal valued at $1.55 per share, which represented a 20% premium…

Wednesday Sep 09, 2026 - 10:29 am

InvestorNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints Andrew Elinesky CEO, Advances Trafigura Due Diligence

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the appointment of Andrew Elinesky as CEO, effective immediately, and provided updates on its Beacon Gold Mill and Trafigura Canada Limited due diligence for proposed prepayment and gold doré offtake arrangements. Elinesky brings more than two decades of senior executive and financial leadership experience and most recently served as…

Wednesday Sep 09, 2026 - 10:17 am

InvestorNewsBreaks – Kairos Pharma Ltd. (NYSE American: KAPA) CEO to Present at H.C. Wainwright 28th Annual Global Investment Conference

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, announced that CEO and Chairman John Yu, MD, will present a corporate overview in person at the H.C. Wainwright 28th Annual Global Investment Conference, taking place Sept. 14-16, 2026, at the Lotte New York Palace Hotel. To view the full press release, visit https://ibn.fm/NrBQD About Kairos Pharma Ltd. Based in Los Angeles,…

Wednesday Sep 09, 2026 - 10:00 am

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO to Attend Inaugural Nasdaq LaB Biotech Summit

Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, at Nasdaq MarketSite in New York. The summit will bring together biotechnology executives, investors and industry leaders for an evening of thought leadership and networking. To view the full press release, visit https://ibn.fm/GJlRi About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under…

Wednesday Sep 09, 2026 - 10:00 am

InvestorNewsBreaks – Fairchild Gold (TSX-V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) Engages TerraEye for Property-Wide Exploration Program at Golden Arrow

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising. Fairchild Gold (TSX-V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) engaged TerraEye to conduct a property-wide satellite-based spectral mapping and structural interpretation program at its 100%-owned Golden Arrow Gold-Silver Project in Nye County, Nevada. The program will combine satellite spectral analysis, image enhancement, structural lineament interpretation and AI-assisted pattern recognition to…

Wednesday Sep 09, 2026 - 9:50 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) to Participate in IPAC-RS 2026 Nasal Innovation Forum

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, taking place Sept. 16-17, 2026, in Jersey City, New Jersey. CEO Eric Weisblum said the forum provides an opportunity to engage with experts in nasal drug development as…

Wednesday Sep 09, 2026 - 9:40 am

InvestorNewsBreaks – Nicola Mining Inc. (NASDAQ: NICM) (TSXV: NIM) (FSE: HLIA) Reports Treasure Mountain Mine in Better-Than-Anticipated Condition Ahead of Planned 2027 Restart

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising. Nicola Mining (NASDAQ: NICM) (TSXV: NIM) (FSE: HLIA) announced the results of an independent underground inspection and factual assessment of its Treasure Mountain Silver Mine in British Columbia as the company evaluates reopening the mine in 2027. McElhanney Ltd., an independent Canadian engineering and consulting firm, found the mine to…

Wednesday Sep 09, 2026 - 9:31 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial Following FDA Clearance for Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the company’s Lucid-MS drug candidate and its recent FDA clearance to begin a phase 2 clinical trial. The editorial, “A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach,” highlights Lucid-MS as a patented, first-in-class candidate designed to protect and potentially repair the myelin…

Wednesday Sep 09, 2026 - 9:21 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Responds to Shareholder Litigation, Says Operational Priorities Remain Unchanged

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company focused on data monetization, credentialing, digital engagement, real-world asset (“RWA”) tokenization and spatial audio technologies, issued a statement in response to recently filed shareholder litigation and related notices being circulated by plaintiffs’ law firms. The company said it intends to vigorously defend itself against the claims, a number of which concern subjects previously raised in an Oct. 31, 2025, short-seller…

Wednesday Sep 09, 2026 - 9:20 am

InvestorNewsBreaks – Frontieras North America Signs LOI With Cora Terminal for Multi-Phase FASForm(TM) Deployment in Illinois

Frontieras North America the energy and environmental technology company commercializing FASForm(TM) Solid Carbon Fractionation, announced it has entered into a Letter of Intent (“LOI”) with Cora Terminal, LLC, a joint venture between Watco Companies, LLC and SCH Services, LLC, for phased development of FASForm(TM) production capacity at the Cora Terminal in Rockwood, Illinois. Under the contemplated structure, Frontieras would initially lease approximately 85 acres for…

Wednesday Sep 09, 2026 - 9:14 am

InvestorNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) CEO to Participate in H.C. Wainwright 28th Annual Global Investment Conference

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising. Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), announced that CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference, taking place Sept. 14-16, 2026, in New York City. The fireside chat will be webcast live Sept. 14…

Wednesday Sep 09, 2026 - 9:10 am

InvestorNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) Rebrands MainLine and ShuntingYard Systems as TrackScout and YardFlow Flex

Rail Vision (NASDAQ: RVSN, FSE: C80), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, announced new branding for its existing MainLine and ShuntingYard products, which will now be marketed as TrackScout and YardFlow Flex, respectively. TrackScout is the company’s long-range AI perception system for mainline freight and passenger rail networks, detecting and classifying hazards in real time at ranges…

Wednesday Sep 09, 2026 - 9:00 am

InvestorNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Highlights Nationwide Portfolio of Modular Housing Deployments

BOXABL (NASDAQ: BXBL) an innovative technology company transforming the housing market with its modular building systems, highlighted a portfolio of completed and in-progress projects demonstrating deployments of its factory-built housing system nationwide. Projects include a permanent 12-unit park-model RV Casita installation at American Campground in Las Vegas, wildfire relief support in Pasadena, California, a 12-unit stacked Casita project for Catholic Charities in Oklahoma City and…

Tuesday Sep 08, 2026 - 2:00 pm

InvestorNewsBreaks – Mobix Labs, Inc. (NASDAQ: MOBX) Secures Initial F-16 Component Production Order

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for…

Tuesday Sep 08, 2026 - 11:31 am

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Publishes Executive Protection Field Brief Ahead of GSX 2026

Knightscope (NASDAQ: KSCP), a security technology company building an Autonomous Security Force, announced that Founder, Chairman and CEO William Santana Li will present at a Tribe Public webinar and Q&A event titled “Building America’s Autonomous Security Force With AI, Robotics, and Humans” on Sept. 10 at 11:30 a.m. ET. The presentation will examine Knightscope model combining autonomous machines, AI-driven software and human security professionals into an integrated operation. Knightscope said…

Tuesday Sep 08, 2026 - 11:20 am

InvestorNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Refocuses R&D Portfolio on NanoAb Platform and CDMO Growth

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining immunology therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), announced a strategic refocusing of its R&D portfolio following the Aug. 31 expiration and termination of its option and license arrangements with PinCell S.r.l. relating to PC111. Scinai said the decision was not driven by any new negative scientific finding regarding PC111 and will allow the company to concentrate R&D resources on its NanoAb platform while preserving…

Tuesday Sep 08, 2026 - 11:12 am

InvestorNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Showcases Neural Sensing Technology for Physical AI and Humanoid Robotics

Wearable Devices (NASDAQ: WLDS), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it will showcase its neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026 in Tel Aviv. The company technology is designed to complement vision-based training data with synchronized signals associated with human movement, muscle activation and intent. Wearable Devices said its multi-channel sEMG array captures motor unit action potentials before movement becomes visible and combines…

Tuesday Sep 08, 2026 - 11:10 am

InvestorNewsBreaks – Roth Capital Partners Hosts and Sponsors Investor Events Through June 2027

Roth Capital Partners is scheduled to host and sponsor more than a dozen investor events from September 2026 through June 2027, including seven ROTH-hosted conferences focused on healthcare, nuclear technology, solar and storage, technology and other growth sectors. Upcoming hosted events include the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29 in New York, the inaugural ROTH Critical Mass in Emerging Nuclear Technology on…

Tuesday Sep 08, 2026 - 9:53 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets Sept. 15 Launch for Three Data Exchange Platforms

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company, announced that its Information Data Exchange(R) (“IDE(R)”), NIL Vault (“NILv(TM)”) and American Political Exchange (“APEX(TM)”) are scheduled to launch Sept. 15, marking the company transition from infrastructure development toward commercial deployment. IDE(R), the company flagship exchange platform, is designed to enable data and other real-world assets to be authenticated, valued, tokenized and monetized while allowing owners to retain control of their underlying…

Tuesday Sep 08, 2026 - 9:50 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Registers Phase II Ebola Trial for NV-387 Oral Gummies

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of antiviral drugs, announced that its phase II clinical trial evaluating NV-387 Oral Gummies as a treatment for Bundibugyo ebolavirus and other Ebola viruses in the Democratic Republic of Congo (“DRC”) has been registered in the Pan African Clinical Trials Registry under identification number PACTR202608748555077. The company previously received local regulatory approval from ACOREP to begin the…

Tuesday Sep 08, 2026 - 9:40 am

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced that it received a Sept. 2 Notice of Publication from the U.S. Patent and Trademark Office (“USPTO”) for commercial brand name trademarks associated with its lead abuse-deterrent fentanyl transdermal system. The trademarks will be published in the USPTO Trademark Official Gazette and, if no objections are filed during the 30-day opposition period, the USPTO…

Tuesday Sep 08, 2026 - 9:30 am

InvestorNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Sets Q4 Biotech Spin-Off as Company Sharpens Critical Minerals Focus

Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements. The company also…

Tuesday Sep 08, 2026 - 9:20 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) was featured in BioMedWire editorial coverage highlighting FDA clearance of the company Investigational New Drug (“IND”) application to begin a randomized, double-blind, placebo-controlled phase 2 trial of Lucid-MS in people with multiple sclerosis (“MS”). Lucid-MS, also known as Lucid-21-302, is a patented, first-in-class drug candidate designed…

Tuesday Sep 08, 2026 - 9:16 am

InvestorNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Management Team as Santa Fe Mine Advances Toward 2027 Production Restart

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) announced three additions to its management team as the company continues its transition from mine developer to mine builder and targets a 2027 production restart at the Santa Fe Mine. Tony Gesualdo has rejoined Lahontan as vice president of exploration after previously serving as exploration manager from 2020…

Tuesday Sep 08, 2026 - 9:10 am

InvestorNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Retains P&E Mining Consultants to Support Murdock Mountain Project

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising. Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF), a B.C.-based organic sedimentary phosphate exploration company, retained P&E Mining Consultants Inc. to provide independent technical support for its wholly owned Murdock Mountain Property in Elko County, Nevada. P&E will support ongoing technical evaluation, geological modeling and staged de-risking of the…

Tuesday Sep 08, 2026 - 9:09 am

InvestorNewsBreaks – American Fusion Inc. (OTC: AMFN) Expands U.S. Patent Portfolio to 130 Applications, Advances National Exchange Uplisting Plans

American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), reported the filing of 30 additional U.S. patent applications, expanding its intellectual property portfolio to 130 pending U.S. applications. The latest filings cover additional configurations and components of the Texatron(TM) platform, including aluminum fusion-confinement structures, toroidal and rifled chamber geometries, conductive components, helium-3 and deuterium fuel-injection configurations and electronic control systems. American Fusion has set an objective of filing more than 260 U.S. patent…

Tuesday Sep 08, 2026 - 9:02 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Promotes Thomas Englese to Chief Commercial Officer

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated, commercial-stage biopharmaceutical company, announced the promotion of Thomas Englese to chief commercial officer, effective immediately. Englese, who has served as executive vice president of commercial operations since September 2024, will continue to oversee sales, marketing, market access and commercial operations for TONMYA, Tonix treatment for fibromyalgia in adults, as well as Zembrace(R) SymTouch(R) and Tosymra(R) for acute migraine in adults. President and…

Tuesday Sep 08, 2026 - 9:00 am

InvestorNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Expands Lawson Natural Hydrogen System With Continued Drilling

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. Figure 1: Drilling at Lawson 3 Well, Genesis Trend (Aug. 2026) MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) reported that ongoing commercial validation drilling at the Lawson Complex 1 in south-central Saskatchewan has triangulated a large Natural Hydrogen system following completion of the Lawson 3 well, while…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions